Now showing items 91-100 of 122
Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids
(Wiley Periodicals, Inc., 2019-01)
Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients
(Wiley Periodicals, Inc., 2017-09)
The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease
(Wiley Periodicals, Inc.Peking University Medical Press, 2017-10)
Predicting corticosteroid‐free endoscopic remission with vedolizumab in ulcerative colitis
(Wiley Periodicals, Inc., 2018-03)
Editorial: visceral fat as a predictor of post‐operative recurrence of Crohn’s disease
(Wiley Periodicals, Inc., 2017-06)
Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
(Blackwell Publishing Ltd, 2005-03)
Liver biopsy in the real world—reporting, expert concordance and correlation with a pragmatic clinical diagnosis
(Wiley Periodicals, Inc., 2021-12)
Treatment considerations in Helicobacter pylori management
(Wiley Periodicals, Inc., 2022-01)
Systematic review: development of a consensus code set to identify cirrhosis in electronic health records
(Wiley Periodicals, Inc., 2022-03)
Outcomes after hepatic encephalopathy in population- based cohorts of patients with cirrhosis
(Wiley Periodicals, Inc., 2020-06)